IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
Les biomarqueurs prédictifs dans le cancer colorectal
APMG Colon Molecular Pathways
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Kras in metastatic colorectal cancer
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Colorectal Cancer
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
:quality(90)/ "Roche | Cancer du côlon : les principales mutations")
Roche | Cancer du côlon : les principales mutations
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS
Integrated multi-omics characterization of KRAS mutant colorectal cancer
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
